When it comes to the brain and human cognition, there is a persistent myth that never seems to go away, and not a single word ...

Description: Is Telekinesis Actually Real? I trained like eleven from stranger things All stunts were done under safety ...

A biotech start-up is testing a novel way of efficiently producing pharmaceutical drugs. A biotech start-up is testing a novel way of efficiently producing pharmaceutical drugs. A chicken egg at Neion ...

Illustration by The Atlantic. Source: Universal History Archive / Getty. The problem with horses—one of the problems with horses, I say as a former horse girl—is that they are as stubborn as mules.

March 24 (Reuters) - The New York Stock Exchange, part of Intercontinental Exchange (ICE.N), opens new tab, announced a collaboration on Tuesday with digital asset company Securitize to help create ...

The New York Stock Exchange said Tuesday that it was joining with Securitize to develop its tokenized securities trading platform. Securitize will become NYSE’s first digital transfer agent, which ...

Jeff Bezos’ Blue Origin is seeking permission to deploy nearly 52,000 satellites capable of handling artificial-intelligence computing into orbit. The company said in a filing Thursday that its ...

Jie Wu, an engineering graduate student, was studying a type of striking white beetle found in Southeast Asia and attempting to figure out how to mimic its brilliant color when an unexpected discovery ...

Samsung Electronics (SSNLF) is collaborating with Nvidia (NVDA) to accelerate the development of next-generation NAND flash memory chips, Seoul Economic Daily reported, citing industry sources. The ...

CVS Health is making investments in digital health and patient engagement tech across the enterprise, including a partnership with Simile to lean on "agentic twins" to test and pilot new programs. The ...

In his State of the Union address Tuesday, President Donald Trump seemed to offer another rationale for possible military action against Iran, saying it was working to develop missiles that could ...

Novo Nordisk struck a deal valued at up to $2.1 billion to license drug-delivery technologies from Vivtex to develop next-generation oral medicines for obesity, diabetes and associated diseases. The ...